Overall, the presented data support the role of PS receptors TIM-1 and CD300a in ZIKV infection and provide insights into the possibility of developing PS inhibitors targeting this universal entry pathway [61,62]. The gene discussed is HAVCR1; the disease is Zika virus infectious disease.